Related Experiment Video
Updated: Aug 5, 2026
12:05
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
Immunophenotypic analysis of myelodysplastic syndromes
M Consuelo Del Cañizo1, M Eugenia Fernández, Antonio López
1Servicio de Hematología, Hospital Universitario de Salamanca, Paseo San Vicente 58-182, 3700 Salamanca, Spain. concarol@usal.es
Haematologica
|April 19, 2003
Summary
Myelodysplastic syndromes (MDS) show distinct immunophenotypic differences compared to normal individuals, with aberrant cell distributions and maturation arrests. These findings aid in diagnosing questionable MDS cases.
Area of Science:
- Hematology
- Immunophenotyping
- Cell biology
Background:
- Limited data exists on immunophenotypic characteristics of myelodysplastic syndromes (MDS).
- Established value of immunophenotyping in hematologic malignancies contrasts with scarce MDS information.
Purpose of the Study:
- To investigate immunophenotypic differences between MDS patients and healthy individuals.
- To identify changes in cell lineage distribution, phenotypic aberrations, and maturation blockades in MDS.
Main Methods:
- Comparative analysis of bone marrow cell populations using flow cytometry.
- Assessment of CD34+ cell proportions and differentiation pathways.
Main Results:
- MDS patients exhibit increased bone marrow CD34+ cells, with a higher proportion committed to the myeloid lineage.
- Aberrant phenotypes are observed in 90% of MDS patients, with maturational arrests in monocytic differentiation pathways.
- MDS shows an increased monocytic and decreased neutrophil cell proportion, leading to a lower neutrophil/monocytic ratio.
Conclusions:
- MDS patients frequently display abnormal cell distribution, aberrant phenotypes, and maturational arrests.
- Immunophenotypic aberrations can assist in diagnosing challenging MDS cases.
- Findings highlight distinct cellular and maturational defects in MDS.
